Bengt-Harald Jonsson
Corporate Officer/Principal en University of Linköping .
Perfil
Bengt-Harald Jonsson is currently a Professor of Molecular Biotechnology at the University of Linköping.
He previously worked as a Director at ModPro AB.
Cargos activos de Bengt-Harald Jonsson
| Empresas | Cargo | Inicio |
|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | 30/10/2009 |
Antiguos cargos conocidos de Bengt-Harald Jonsson.
| Empresas | Cargo | Fin |
|---|---|---|
ModPro AB
 ModPro AB Medical SpecialtiesHealth Technology ModPro AB is a holding company that develops novel proprietary concept for recognition and binding of proteins in vitro and in vivo. It is a biopharmaceutical company that designs and produces synthetic binders for proteins for applications in diagnostics, drug development, molecular imaging, and for protein purification. Its technology combines small organic molecules, or "hot spot" mimics with polypeptides from a designed set to form powerful binders for proteins. Its concept is unprecedented and analogous with protein surfaces involved in protein-protein interactions. The company was founded by Lars Harald Baltzer in 2002 and is headquartered in Uppsala, Sweden. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
ModPro AB
ModPro AB Medical SpecialtiesHealth Technology ModPro AB is a holding company that develops novel proprietary concept for recognition and binding of proteins in vitro and in vivo. It is a biopharmaceutical company that designs and produces synthetic binders for proteins for applications in diagnostics, drug development, molecular imaging, and for protein purification. Its technology combines small organic molecules, or "hot spot" mimics with polypeptides from a designed set to form powerful binders for proteins. Its concept is unprecedented and analogous with protein surfaces involved in protein-protein interactions. The company was founded by Lars Harald Baltzer in 2002 and is headquartered in Uppsala, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Bengt-Harald Jonsson